$80.70

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI02425_100_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Fmoc-L-isoleucine
Brand Name
Chem Impex
Product Number
02425
CAS
71989-23-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
2724629
IUPAC Name
(2S,3S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylpentanoic acid
InChI Key
QXVFEIPAZSXRGM-DJJJIMSYSA-N
SMILES
CCC@H(C)C@@H(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Application

Fmoc-L-isoleucine is widely utilized in research focused on

Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, allowing researchers to create complex structures for studying protein interactions and functions.

Drug Development: In pharmaceutical research, it is used to develop peptide-based drugs, particularly in targeting specific diseases, due to its ability to enhance the stability and bioavailability of therapeutic agents.

Biotechnology: Fmoc-L-isoleucine plays a crucial role in the production of recombinant proteins, aiding in the development of biologics and vaccines by providing essential amino acids for protein folding and function.

Analytical Chemistry: It is utilized in various analytical techniques, such as mass spectrometry, to help identify and quantify peptides, making it invaluable for quality control in pharmaceutical manufacturing.

Research in Neuroscience: This compound is used in studies related to neurotransmitter synthesis and function, contributing to the understanding of neurological disorders and potential treatments.

References Data Source From Pubchem

Water-based coupling of amino acids for sustainable solid-phase peptide synthesis

Publication Name: Nature Sustainability
Publication Date: 2026-02-03
DOI: 10.1038/s41893-025-01761-z

Symplocamide A as marine-derived proteasome inhibitor: a promising scaffold for targeted cancer therapy

Publication Name: Medical oncology (Northwood, London, England)
Publication Date: 2025-07-19
DOI: 10.1007/s12032-025-02870-7

Discordance between in silico and in vitro results on proteolytic stability of milk protein-derived DPP-4 inhibitory peptides

Publication Name: European Food Research and Technology
Publication Date: 2025-07-09
DOI: 10.1007/s00217-025-04833-8

Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants

Publication Name: Nature Biomedical Engineering
Publication Date: 2025-05-29
DOI: 10.1038/s41551-025-01404-w

Stabilization of a miniprotein fold by an unpuckered proline surrogate

Publication Name: Communications Chemistry
Publication Date: 2025-03-12
DOI: 10.1038/s42004-025-01474-6